Mirae Asset Global Investments Co., Ltd. Intra Cellular Therapies, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,152 shares of ITCI stock, worth $228,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,152
Previous 43,754
92.8%
Holding current value
$228,267
Previous $3.03 Million
92.9%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ITCI
# of Institutions
400Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$696 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$458 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$269 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$249 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$217 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.84B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...